BUPivacaine HCl 0.25% Preservative Free (2.5 mg/mL) 500 mL in On-Q C-bloc (2-14 mL/hr) bag, Heali...
FDA Drug Recall #D-1422-2014 — Class II — February 13, 2014
Recall Summary
| Recall Number | D-1422-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 13, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Healix Infusion Therapy, Inc. |
| Location | Sugar Land, TX |
| Product Type | Drugs |
| Quantity | 10 bags |
Product Description
BUPivacaine HCl 0.25% Preservative Free (2.5 mg/mL) 500 mL in On-Q C-bloc (2-14 mL/hr) bag, Healix Infusion Therapy, Inc., 1075 West Park One Drive, Suite 200, Sugar Land, Texas 77478, NDC 75901-7210-53.
Reason for Recall
Presence of Particulate Matter: The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by the supplier due to a customer complaint of visible particles embedded in the glass vial.
Distribution Pattern
Texas
Lot / Code Information
Lot #: 6156-0, Exp 03/07/14
Other Recalls from Healix Infusion Therapy, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1555-2014 | Class II | fentaNYL 5000 mcg/250 mL (20 mcg/mL) in 0.9% So... | Jun 27, 2014 |
| D-1551-2014 | Class II | fentaNYL 1500 mcg/30 mL (50 mcg/mL) in prefille... | Jun 27, 2014 |
| D-1552-2014 | Class II | fentaNYL 2500 mcg/250 mL (10 mcg/mL) in 0.9% So... | Jun 27, 2014 |
| D-1554-2014 | Class II | fentaNYL 2750 mcg/55 mL (50 mcg/mL) in prefille... | Jun 27, 2014 |
| D-1553-2014 | Class II | fentaNYL 200 mcg/100 mL (2 mcg/mL) and Ropivaca... | Jun 27, 2014 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.